Want to track LENZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LENZ Therapeutics, Inc. (LENZ) Statistics
Valuation metrics
Market Cap 212.9M
Enterprise value 187.73M
Trailing P/E (ttm) -1.95
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 10.11
Price/Book (mrq) 0.86
Enterprise Value/Revenue 8.94
Enterprise Value/EBITDA -1.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 248.72K
Average volume (90 days) 989.09K
Price summary
52-Week low 6.29
52-Week high 50.4
Beta -
50-Day moving average 8.47
200-Day moving average 14.13
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 21 Mar 2024
Ex-Dividend Date 22 Mar 2024
Last split factor 1:7
Last split Date 22 Mar 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.19%
Operating margin -5.64%
Operational effectiveness
Return on assets -0.4%
Return on equity -0.47%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 10.4%
Book value per share (mrq) 7.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
